Barclays’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $26M | Buy |
|
|||||
|
2023
Q3 | $12.5M | Sell |
|
|||||
|
2023
Q2 | $18.3M | Buy |
|
|||||
|
2023
Q1 | $5.2M | Sell |
|
|||||
|
2022
Q4 | $5.79M | Sell |
|
|||||
|
2022
Q3 | $6.99M | Buy |
|
|||||
|
2022
Q2 | $306K | Sell |
|
|||||
|
2022
Q1 | $1.26M | Sell |
|
|||||
|
2021
Q4 | $5.31M | Buy |
|
|||||
|
2021
Q3 | $2.32M | Buy |
|
|||||
|
2021
Q2 | $1.98M | Sell |
|
|||||
|
2021
Q1 | $3.64M | Sell |
|
|||||
|
2020
Q4 | $4.14M | Buy |
|
|||||
|
2020
Q3 | $637K | Sell |
|
|||||
|
2020
Q2 | $1.03M | Buy |
|
|||||
|
2020
Q1 | $274K | Sell |
|
|||||
|
2019
Q4 | $387K | Buy |
|
|||||
|
2019
Q3 | $37K | Buy |
|